DJIA 18,232.02 0.00 0.00%
NASDAQ 5,089.36 0.00 0.00%
S&P 500 2,126.06 0.00 0.00%
market minute promo

171.94 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $171.94 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $167.69
Previous Close $171.94
Daily Range $167.31 - $172.65
52-Week Range $150.06 - $203.30
Market Cap $34.3B
P/E Ratio 58.88
Dividend (Yield) $0.00 (0.0%)
Volume 2,570,610
Average Daily Volume 2,261,746
Current FY EPS $4.82

Sector

Healthcare

Industry

Drug Makers

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary Rss Feed

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

'Fast Money' Recap: This Stock Has Risen Every Summer for the Past Decade

Why I Bought The Dips In Both Gilead And Achillion Today

Consolidation Is Good - Cramer's Mad Money (5/18/15)

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog

Short Sellers Start to Get Nervous on Biotech

ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary

ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary

Oppenheimer Downgrades Dyax

Yellen Sounds A Warning, Nasdaq Falls But Biotech Hangs On

Investors Just Doubled Their Money on This Stock

Alexion is paying $8.4 billion to buy Synageva, a company without any sales, so in today's episode we're digging into this deal to see what it may mean to biotech investors.

See More ALXN News...

ALXN's Top Competitors

ALXN $171.94 (0.00%)
Current stock: ALXN
AMGN $163.58 (0.00%)
Current stock: AMGN
GILD $111.71 (0.00%)
Current stock: GILD
BIIB $398.68 (0.00%)
Current stock: BIIB